Screener
Neurocrine Biosciences NBIX Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's restricted cash?
- Neurocrine Biosciences (NBIX) reported restricted cash of $8M in Q1 2026.
- How has Neurocrine Biosciences's restricted cash changed year-over-year?
- Neurocrine Biosciences's restricted cash decreased by 0.0% year-over-year, from $8M to $8M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Neurocrine Biosciences's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude